A Double-Blind, Placebo-Controlled, Randomized, Single Ascending Dose Study to Investigate Safety, Tolerability, and Pharmacokinetics of JNJ-63623872 in Healthy Japanese Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 24 Sep 2015
At a glance
- Drugs Pimodivir (Primary)
- Indications Infections
- Focus Pharmacokinetics
- Sponsors Janssen Infectious Diseases BVBA
- 21 Sep 2015 Status changed from recruiting to completed as reported by ClinicalTrials.govrecord.
- 11 Jun 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.
- 22 Apr 2015 New trial record